Intranasal Drug Delivery: How, Why and What for?
Open accessThe DOI matches its Crossref record; 174 of the 175 references it cites were found in a registry or an index.
Abstract
Over the last decade the interest in intranasal delivery as a non-invasive route for drug administration has been exponentially increased. Since the nasal mucosa offers numerous benefits as a target issue for drug delivery, a wide variety of therapeutic compounds may be administered intranasally for topic, systemic and central nervous system action. The present paper reviews the relevant aspects of nasal anatomy, physiology and histology, and refers to the biological, physicochemical and pharmaceutical factors that must be considered during the process of discovery and development of nasal drugs as well as in their incorporation in appropriate nasal pharmaceutical formulations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It is non-invasive, painless, non-stressful, and relatively easy to perform without requiring a medical specialist [246,247,248].”
From Alzheimer's Disease: Treatment Strategies and Their Limitations. (2022) · cites this paper as [248]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Introduction and General Overview of Cyclodextrin Chemistry
Szejtli, J. (1998) · Chemical Reviews · doi:10.1021/cr970022c · Cited by 5,016
Chitosan Chemistry and Pharmaceutical Perspectives
Kumar, M. N. V. R., Muzzarelli, R. A. A., Muzzarelli, C., Sashiwa, H., & Domb, A. J. (2004) · Chemical Reviews · doi:10.1021/cr030441b · Cited by 2,938
Encyclopedia of Pharmaceutical Technology
Swarbrick, J. (2013) · CRC Press eBooks · doi:10.1201/b19309 · Cited by 1,794
Encyclopedia of pharmaceutical technology
(2003) · Choice Reviews Online · doi:10.5860/choice.40-6157 · Cited by 1,743
Abramson, M. H. (1996) · The Endocrinologist · doi:10.1097/00019616-199603000-00014 · Cited by 1,400
The Lung: Scientific Foundations
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-6-503_2 · Cited by 1,190
Nasal drug delivery—possibilities, problems and solutions
Illum, L. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00363-2 · Cited by 1,102
Thorne, R. G., Pronk, G. J., Padmanabhan, V., & Frey, W. H. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.05.029 · Cited by 958
Transport of drugs from the nasal cavity to the central nervous system
Illum, L. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00087-7 · Cited by 907
Hanson, L. R., & Frey, W. H. (2008) · BMC Neuroscience · doi:10.1186/1471-2202-9-s3-s5 · Cited by 697
Research works printed but not linked: 5
- [27]27. Stevens A., Lowe J., Human histology, Mosby, Philadelphia, USA, 1997.
- [35]35. Dae-Duk Ki, Drug Absorption Studies: In situ, In vitro and In silico models, chapter 9, Springer, USA, 2007.
- [56]56. Varshosaz J, Sadrai H, Heidari A. Nasal delivery of insulin using bioadhesive chitosan gels. Drug Deliv, 2006; 13:31-38.
- [72]72. Belshe RB, Newman FK, Anderson EL, Wright PF, Karron RA, Tollefson S, Henderson FW, Meissner HC, Madhi S, Roberton D, Marshall H, Loh R, Sly P, Murphy B, Tatem JM, Randolph V, Hackell J, Gruber W, Tsai TF. Evaluation of combined live, attenuated respiratory syncytial virus and parainfluenza 3 virus in infants and young children. J Infect Dis, 2004; 190:2096-2103.
- [113]113. Hussain A.A., Bawarshi-Nassar R., Huang C.H., Transnasal Systemic Medications. Elsevier, Amsterdam, 1985. 123.
Cited by
Items 301–400 of 661
Intranasal administration: a prospective drug delivery route to the brain
Privalova, A. M., Gulyaeva, N. V., & Букреева, Т. В. (2012) · Neurochemical Journal · doi:10.1134/s1819712412020080 · Cited by 23
Li, C., Xu, F., Xie, D.-M., Yu, J., Shang, M., Liu, G., Wang, X., & Cai, S. (2014) · Molecules · doi:10.3390/molecules19044857 · Cited by 21
Lee, D., Shen, A. M., Shah, M., Garbuzenko, O. B., & Minko, T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910357 · Cited by 20
“Its advantages include non-invasive application, simple administration, and by-passing of the hepatic fi rst-pass metabolism [17,18].”
BackgroundVarese, A., Paletta, A. L., Ceballos, A., Palacios, C., Figueroa, J. M., & Dugour, A. V. (2021) · Frontiers in Virology · doi:10.3389/fviro.2021.746824 · Cited by 20
Nazar, H., Roldo, M., Fatouros, D. G., van der Merwe, S. M., & Tsibouklis, J. (2012) · Therapeutic Delivery · doi:10.4155/tde.12.16 · Cited by 22
Chattopadhyay, S., Das, S., & SARMA, K. N. (2021) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2021v13i2.40404 · Cited by 20
The Potential of the Nose-to-Brain Delivery of PACAP for the Treatment of Neuronal Disease
Cherait, A., Banks, W. A., & Vaudry, D. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15082032 · Cited by 20
Intranasal Nanoparticulate Delivery Systems for Neurodegenerative Disorders: a Review
Babu, S. R., Shekara, H. H., Sahoo, A. K., Vardhan, P. V. H., Thiruppathi, N., & Venkatesh, M. P. (2023) · Therapeutic Delivery · doi:10.4155/tde-2023-0019 · Cited by 22
Polysaccharides: New Frontiers for Nasal Administration of Medicines
Clementino, A., Climani, G., Bianchera, A., Buttini, F., & Sonvico, F. (2025) · Polysaccharides · doi:10.3390/polysaccharides6010006 · Cited by 21
In vitro Nasal Cell Culture Systems for Drug Transport Studies
Cho, H., Termsarasab, U., Kim, J. S., & Kim, D.-D. (2010) · Journal of Pharmaceutical Investigation · doi:10.4333/kps.2010.40.6.321 · Cited by 22
Merelli, A., Caltana, L. R., Lazarowski, A., & Brusco, A. (2011) · Drug metabolism and drug interactions · doi:10.1515/dmdi.2011.007 · Cited by 19
Vosoughi, P., Naghib, S. M., Jafari, T., & Kangarshahi, B. M. (2025) · Carbohydrate Polymer Technologies and Applications · doi:10.1016/j.carpta.2025.100805 · Cited by 30
Nanoarchitectured Biomaterials: Present Status and Future Prospects in Drug Delivery
Kesrevani, R. K., & Sharma, A. K. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-47347-7.00002-1 · Cited by 23
League-Pascual, J. C., McCully, C. L., Shandilya, S., Ronner, L., Rodgers, L. T., Cruz, R., Peer, C. J., Figg, W. D., & Warren, K. E. (2017) · Journal of Neuro-Oncology · doi:10.1007/s11060-017-2388-x · Cited by 20
Hayes, S. H., Liu, Q., Selvakumaran, S., Haney, M. J., Batrakova, E. V., Allman, B. L., Walton, P. A., Kiser, P. K., & Whitehead, S. N. (2021) · Neurotoxicity Research · doi:10.1007/s12640-021-00390-6 · Cited by 18
Intranasal lipid nanocarriers: Uptake studies with fluorescently labeled formulations
Muntoni, E., Marini, E., Ferraris, C., Garelli, S., Capucchio, M. T., Colombino, E., Panciani, P. P., & Battaglia, L. (2022) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2022.112470 · Cited by 19
McCollum, C. R., Courtney, C. M., O’Connor, N. J., Aunins, T. R., Ding, Y., Jordan, T. X., Rogers, K. L., Brindley, S. M., Brown, J. M., Nagpal, P., et al. (2022) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.2c00510 · Cited by 18
PULMONARY DRUG DELIVERY SYSTEM: REVIEW
Chaturvedi, N. (2013) · Cited by 18
Lorenzett, A. K. P., de Lima, V. A., da Fonseca, C. O. P., & Mainardes, R. M. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17091104 · Cited by 21
Porfiryeva, N. N., Moustafine, R. I., & Khutoryanskiy, V. V. (2026) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2026.2628612 · Cited by 23
Furquan, A., Hafeez, A., & Rahman, M. A. (2023) · Journal of Nanoparticle Research · doi:10.1007/s11051-023-05880-6 · Cited by 20
The development of a human Brucella mucosal vaccine: What should be considered?
Tian, T., Zhu, Y., Shi, J., Shang, K., Yin, Z., Shi, H., He, Y., Ding, J., & Zhang, F. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122986 · Cited by 18
Intranasal midazolam for seizure cessation in the community setting.
Zelcer, M., & Goldman, R. D. (2016) · Europe PMC (PubMed Central) · Cited by 17
Inoue, D., Kimura, S., Kiriyama, A., Katsumi, H., Yamamoto, A., Ogawara, K., Higaki, K., Tanaka, A., Yutani, R., Sakane, T., et al. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00464 · Cited by 17
Developments in the discovery and design of intranasal antidepressants
Panek, M., Kawalec, P., Pilc, A., & Lasoń, W. (2020) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2020.1776697 · Cited by 17
Sex differences in the cerebroprotection by Nestorone intranasal delivery following stroke in mice
Fréchou, M., Zhu, X., Kumar, N., Sitruk-Ware, R. L., Schumacher, M., Mattern, C., & Guennoun, R. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108760 · Cited by 17
Dkhar, L., Bartley, J., White, D. E., & Seyfoddin, A. (2017) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2017.1389956 · Cited by 19
Potential Use of Nanomedicine for the Anti-inflammatory Treatment of Neurodegenerative Diseases
Otero, M. D. C., Espinosa‐Oliva, A. M., Herrera, A. J., García-Domínguez, I., Arévalo, M. F., Martín‐Banderas, L., & de Pablos, R. M. (2018) · Current Pharmaceutical Design · doi:10.2174/1381612824666180403113015 · Cited by 20
McCormick, A. A., Shakeel, A., Yi, C., Kaur, H., Mansour, A. M., & Bakshi, C. S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194614 · Cited by 16
Bae, H.-D., Lee, J.-S., Pyun, H., Kim, M., & Lee, K. (2019) · Drug Delivery · doi:10.1080/10717544.2019.1628119 · Cited by 16
Saad, B. B., Tharwat, A. I., Ghobrial, H. N., & Fawal, S. M. M. E. (2020) · Ain-Shams Journal of Anaesthesiology · doi:10.1186/s42077-020-00090-x · Cited by 16
Plant-based drug delivery systems in respiratory diseases
Mehta, M., Sharma, P., Kaur, S., Dhanjal, D. S., Singh, B., Vyas, M., Gupta, G., Chellappan, D. K., Nammi, S., Singh, T. G., et al. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820658-4.00024-8 · Cited by 20
Factors affecting nasal drug delivery and design strategies for intranasal drug delivery
Xiaoyun, H. U., Yue, X., Wu, C., & Zhang, X. (2023) · Journal of Zhejiang University (Medical Sciences) · doi:10.3724/zdxbyxb-2023-0069 · Cited by 18
McCallum, R. W., Parkman, H. P., Fass, R., Bhandari, B. R., Carlson, M. R., & Buck, R. D. (2023) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2023.10.022 · Cited by 16
Intranasal Fluorescent Nanocrystals for Longitudinal In Vivo Evaluation of Cerebral Microlesions
Choi, A. O., & Maysinger, D. (2013) · Pharmaceutical Nanotechnology · doi:10.2174/2211738511301020005 · Cited by 17
Vaiss, D. P., Rodrigues, J. L., Yurgel, V. C., Guedes, F. D. C., da Matta, L. L. M., Barros, P. A. B., Vaz, G. R., dos Santos, R. N., Matte, B. F., Kupski, L., et al. (2024) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2024.106766 · Cited by 15
Recent Advances in Studying In Vitro Drug Permeation Across Mucosal Membranes
Song, J., Xu, Z., Xie, L., & Shen, J. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17020256 · Cited by 15
Corsaro, R., Lombardo, R., Ghelardini, C., Mannelli, L. D. C., Bani, D., Bonaccorso, A., & Pignatello, R. (2022) · Applied Sciences · doi:10.3390/app12052373 · Cited by 17
Spray Dried Levodopa-Doped Powder Potentially for Intranasal Delivery
Liu, X., Yan, S., Li, M., Zhang, S., Guo, G. F., Yin, Q., Tong, Z., Chen, X. D., & Wu, W. D. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14071384 · Cited by 15
Karavasili, C., Katsamenis, O. L., Bouropoulos, N., Nazar, H., Thurner, P. J., van der Merwe, S. M., & Fatouros, D. G. (2014) · Langmuir · doi:10.1021/la5030636 · Cited by 15
Gufford, B. T., Ainslie, G. R., White, J. R., Layton, M. E., Padowski, J. M., Pollack, G. M., & Paine, M. (2017) · Clinical and Translational Science · doi:10.1111/cts.12473 · Cited by 15
Intranasal mucoadhesive microemulsion of mirtazapine: Pharmacokinetic and pharmacodynamic studies
Thakkar, H. P., Patel, A., & Chauhan, N. P. (2013) · Asian Journal of Pharmaceutics · doi:10.4103/0973-8398.110934 · Cited by 15
Routes of Delivery for Biological Drug Products
Irvine, D. J., Su, X., & Kwong, B. (2013) · Wiley eBooks · doi:10.1002/9780470571224.pse521 · Cited by 15
Effectiveness of Intranasal Analgesia in the Emergency Department
Zanza, C., Saglietti, F., Giamello, J. D., Savioli, G., Biancone, D. M., Balzanelli, M. G., Giordano, B., Trompeo, A. C., & Longhitano, Y. (2023) · Medicina · doi:10.3390/medicina59101746 · Cited by 14
A new approach for the treatment of Alzheimer’s disease: insulin-quantum dots
Çamlık, G., Bilakaya, B., Özsoy, Y., & Değim, İ. T. (2023) · Journal of Microencapsulation · doi:10.1080/02652048.2023.2282968 · Cited by 14
THE DEVELOPMENT OF A BRAIN TARGETED MUCOADHESIVE AMISULPRIDE LOADED NANOSTRUCTURED LIPID CARRIER
Tamer, M. A. (2023) · FARMACIA · doi:10.31925/farmacia.2023.5.18 · Cited by 19
Stability of prolin-containing peptides in biological media
Shevchenko, K. V., Nagaev, I. Y., Андреева, Л. А., Shevchenko, V. P., & Myasoedov, N. F. (2019) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20196503180 · Cited by 15
Challenges in the Development and Application of Organ-on-Chips for Intranasal Drug Delivery Studies
Khan, M. U., Cai, X., Shen, Z., Mekonnen, T. T., Kourmatzis, A., Cheng, S., & Gholizadeh, H. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15051557 · Cited by 14
Intranasal Drug Delivery System: A Review
Bava, B., Sharma, K., & Yadav, V. K. (2024) · Research Journal of Science and Technology · doi:10.52711/2349-2988.2024.00009 · Cited by 14
Fallacara, A., Busato, L., Pozzoli, M., Ghadiri, M., Ong, H. X., Young, P. M., Manfredini, S., & Traini, D. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.01.012 · Cited by 14
Fréchou, M., Zhu, X., Lière, P., Pianos, A., Schumacher, M., Mattern, C., & Guennoun, R. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108038 · Cited by 15
Kang, Y., Yan, W., Fang, H., Zhang, G., Du, Y., Wang, L., Cui, H., & Shi, G. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/7908072 · Cited by 15
Intranasal delivery of iron chelators and management of central nervous system disease
Cheng, R., & Kim, J. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1709259 · Cited by 15
Bendas, S., Koch, E. V., Nehlsen, K., May, T., Dietzel, A. H., & Reichl, S. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15092245 · Cited by 13
Tuttle, R. S., Popescu, L., Hill, S., Slanczka, A., Jankowski, J. J., Barre, K., Krueger, E., Slade, D., Croutch, C. R., Robben, M., et al. (2020) · Respiratory Research · doi:10.1186/s12931-020-01343-x · Cited by 13
Effects of subject-variability on nasally inhaled drug deposition, uptake, and clearance
Chari, S., Sridhar, K., & Kleinstreuer, C. (2022) · Journal of Aerosol Science · doi:10.1016/j.jaerosci.2022.106021 · Cited by 13
Ketamine in Trauma: A Literature Review and Administration Guidelines
Reede, K., Bartholomew, R., Nielsen, D., Ahmeti, M., & Zreik, K. (2023) · Cureus · doi:10.7759/cureus.48099 · Cited by 17
Nose-to-Heart Approach: Unveiling an Alternative Route of Acute Treatment
Papakyriakopoulou, P., Valsami, G. N., & Kadoglou, N. P. E. (2024) · Biomedicines · doi:10.3390/biomedicines12010198 · Cited by 13
Ali, M. M., Shoukri, R. A., & Yousry, C. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105693 · Cited by 13
Nasal Delivery of Biopharmaceuticals
Yuba, E., & Kono, K. (2014) · Springer eBooks · doi:10.1007/978-1-4614-9524-6_8 · Cited by 14
Oxytocin modulates mate-guarding behavior in marmoset monkeys
Cavanaugh, J., Mustoe, A. C., Womack, S. L., & French, J. A. (2018) · Hormones and Behavior · doi:10.1016/j.yhbeh.2018.10.009 · Cited by 14
Zech, J., Salaymeh, N., Hunt, N. H., Mäder, K., & Golenser, J. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02106-20 · Cited by 13
Ahonen, K., Lahtinen, M., Valkonen, A., Dračínský, M., & Kolehmainen, E. T. (2010) · Steroids · doi:10.1016/j.steroids.2010.11.007 · Cited by 13
FORMULATION AND OPTIMIZATION OF PROLONGED RELEASE NASAL IN SITU GEL FOR TREATMENT OF MIGRAINE
Godbole, M. D., There, P. W., & Dangre, P. V. (2014) · Indo American Journal of Pharmaceutical Research · Cited by 13
Khalil, R. J. C. D., Mirza, R., Shah, K. U., Khan, A. U., Ismail, I., Shah, S. U., Ullah, W., Niyazi, S., Alanzi, A. R., Gibaud, S., et al. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106125 · Cited by 13
Laube, B. L., Kesavan, J. S., Farias, G., Karavas, N., Blondel, M., & Suman, J. (2024) · Frontiers in Drug Delivery · doi:10.3389/fddev.2024.1456538 · Cited by 12
Intranasal drug delivery: Unlocking the nose-to-brain route for central nervous system therapies
Alwali, B., Parumasivam, T., & Al-Tabakha, M. M. (2026) · International Journal of Pharmaceutics X · doi:10.1016/j.ijpx.2026.100521 · Cited by 28
Recent Advances and Novel Approaches for Nose to Brain Drug Delivery for Treatment of Migraine
Sachan, N., Bahadur, S., & Sharma, P. K. (2019) · Drug Delivery Letters · doi:10.2174/2210303109666190508083142 · Cited by 14
Jha, S., & Mishra, D. (2022) · Pharmaceutical Nanotechnology · doi:10.2174/2211738510666220303160414 · Cited by 14
McCollum, C. R., Courtney, C. M., O’Connor, N. J., Aunins, T. R., Jordan, T. X., Rogers, K. L., Brindley, S. M., Brown, J. M., Nagpal, P., & Chatterjee, A. (2023) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.2c00669 · Cited by 12
VEGF mimic peptides: Potential applications in central nervous system therapeutics
D’Andrea, L. D., Rosa, L. D., Vigliotti, C., & Cataldi, M. (2016) · European Journal of Molecular & Clinical Medicine · doi:10.1016/j.nhtm.2016.12.002 · Cited by 14
Intranasal epinephrine in dogs: Pharmacokinetic and heart rate effects
Dretchen, K. L., Mesa, Z., Robben, M., Slade, D., Hill, S., Croutch, C. R., Kappeler, K. V., & Mesa, M. (2020) · Pharmacology Research & Perspectives · doi:10.1002/prp2.587 · Cited by 15
Road From Nose to Brain for Treatment of Alzheimer: The Bumps and Humps
Kumar, R., Gulati, M., Singh, S. K., Sharma, D., & Porwal, O. (2020) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527319666200708124726 · Cited by 13
Nose as a Route for Drug Delivery
Serralheiro, A., Alves, G., Sousa, J., Fortuna, A. C., & Falcão, A. C. (2013) · Springer eBooks · doi:10.1007/978-3-642-37250-6_15 · Cited by 17
Self-citationAyurvedic Profiling of Alzheimer's Disease.
Bredesen, D. E., & Rao, R. V. (2017) · PubMed · Cited by 13
Nanoparticles in CNS Therapeutics: Pioneering Drug Delivery Advancements
Nayak, U. Y., Halagali, P., Panchal, K. N., Tippavajhala, V. K., Mudgal, J., Radhakrishnan, R. A., & Manikkath, J. (2024) · Current Pharmaceutical Design · doi:10.2174/0113816128328722240828184410 · Cited by 14
Nano-Based Technology in Glioblastoma
Bartusik‐Aebisher, D., Rudy, I., Pięta, K., & Aebisher, D. (2025) · Molecules · doi:10.3390/molecules30173485 · Cited by 12
In Vitro Evaluation and In Vivo Pharmacokinetic Assessment of Intranasal Tadalafil Nanocrystals
Conti, A., Ricci, L., & Esposito, M. (2025) · Annals of Pharmacy Practice and Pharmacotherapy · doi:10.51847/8j1kgy8yw6 · Cited by 11
Mucoadhesion as a strategy to enhance the direct nose-to-brain drug delivery
Patil, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822522-6.00007-2 · Cited by 13
Parvizi, F., Mehrabi, S., Naghizadeh, A., Kamalinejad, M., Goudarzi, S., & Farahmandfar, M. (2022) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-022-03711-0 · Cited by 12
Henriques, P., Bicker, J., Silva, S., Doktorovová, S., & Fortuna, A. C. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.123252 · Cited by 12
Self-citationFormulation of Convenient, Easily Scalable, and Efficient Granisetron HCl Intranasal Droppable Gels
Ibrahim, H. K., Abdelmalak, N. S., & Abdel-Halim, S. A. (2015) · Molecular Pharmaceutics · doi:10.1021/mp500825n · Cited by 11
Rogol, A. D., Tkachenko, N., Badorrek, P., Hohlfeld, J. M., & Bryson, N. (2018) · Canadian Urological Association Journal · doi:10.5489/cuaj.4898 · Cited by 11
Nanostructure self-assembly for direct nose-to-brain drug delivery
Chaud, M. V., Rios, A. C., dos Santos, C. A., de Barros, C. T., de Souza, J. F., & Alves, T. F. R. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-817998-7.00019-7 · Cited by 16
Routes of administration for nanocarriers
Shah, N. K., Guzmán, E. A. T., Wang, Z., & Meenach, S. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816662-8.00006-0 · Cited by 15
Gangane, P. S., Ghormare, N. V., Mahapatra, D. K., & Mahajan, N. M. (2020) · International Journal of Current Research and Review · doi:10.31782/ijcrr.2020.121929 · Cited by 11
Intranasal pitavastatin attenuates seizures in different experimental models of epilepsy in mice
Ashhar, M. U., Ahmad, M. Z., Jain, V. K., Agarwal, N. B., Ahmad, F. J., & Jain, G. K. (2017) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2017.07.004 · Cited by 11
Vladimir, K. (2018) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2018.10.001959 · Cited by 10
Dutta, R., Kolanjiyil, A. V., Walenga, R. L., Chopski, S. G., Kaviratna, A., Mohan, A. R., Newman, B. W., Golshahi, L., & Longest, P. W. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124660 · Cited by 10
Salama, R. M., Yehia, R., Elmongy, N. F., Sallam, A. A., Abdel-Galil, M., Schaalan, M. F., Abdel-Mottaleb, M. M. A., & Bazan, L. S. (2024) · Archiv der Pharmazie · doi:10.1002/ardp.202400641 · Cited by 10
Nanoparticle-Mediated Nose-to-Brain Delivery for Ischemic Stroke Therapy: Preclinical Insights
Park, J., & Riew, T. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17111447 · Cited by 11
Rahamathulla, M., Bindiya, R., Venkatesh, M. P., Pai, D. R., Harshith, H. S., Ghazwani, M., Farhana, S. A., Buddhadev, S. S., Ahmed, M. M., & Pasha, I. (2025) · Scientific Reports · doi:10.1038/s41598-025-32985-w · Cited by 10
Gao, T., Chu, Q., Xing, X., Liu, Y., Fu, S., & Liu, D. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s588836 · Cited by 18
Formulation considerations in enhancing olfactory mucosal deposition for nose-to-brain drug delivery
D’souza, A. A., Kahan, M. S., Yang, A., Padmakumar, S., Bleier, B. S., & Amiji, M. M. (2026) · Drug Delivery and Translational Research · doi:10.1007/s13346-026-02097-7 · Cited by 16
Malyshev, A. V., Sukhanova, I. A., Ushakova, V. M., Zorkina, Y., Abramova, O. V., Morozova, A. Y., Zubkov, E. A., Mitkin, N. A., Pavshintsev, V. V., Doronin, I. I., et al. (2022) · Pharmaceuticals · doi:10.3390/ph15040462 · Cited by 10
Modaresi, M. A., & Shirani, E. (2022) · The European Physical Journal Plus · doi:10.1140/epjp/s13360-022-03067-x · Cited by 10
Nose-to Brain Delivery of Resveratrol, a Non-Invasive Method for the Treatment of Cerebral Ischemia
Alquisiras-Burgos, I., González-Herrera, I. G., Alcalá-Alcalá, S., & Aguilera, P. (2024) · Drugs and Drug Candidates · doi:10.3390/ddc3010007 · Cited by 11
Hypogonadism in Male Infants and Adolescents: New Androgen Formulations
Chioma, L., & Cappa, M. (2021) · Hormone Research in Paediatrics · doi:10.1159/000521455 · Cited by 12
Stability of Proline-Containing Peptides in Biological Media
Shevchenko, K. V., Nagaev, I. Y., Андреева, Л. А., Shevchenko, V. P., & Myasoedov, N. F. (2019) · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry · doi:10.1134/s1990750819030089 · Cited by 10
Che, M. M., Chanda, S., Song, J., Doctor, B. P., Rezk, P. E., Sabnekar, P., Perkins, M. W., Sciuto, A. M., & Nambiar, M. P. (2011) · Toxicology Mechanisms and Methods · doi:10.3109/15376516.2011.562258 · Cited by 10
Metadata
- Authors
- Pires, A., Fortuna, A., Alves, G., & Falcão, A.
- Affiliations
- University of Coimbra (PT)
- University of Beira Interior (PT)
- Venue
- Journal of Pharmacy & Pharmaceutical Sciences
- Publisher
- Frontiers Media SA
- Published
- 2009-10-12
- Volume
- 12
- Issue
- 3
- Pages
- 288
- ISSN
- 1482-1826 (ISSN-L)
- OpenAlex
- W2106536537
- Cited by
- 641
- References
- 175
- Citations by year
- 2026: 31 · 2025: 49 · 2024: 44 · 2023: 45 · 2022: 67 · 2021: 65 · 2020: 48 · 2019: 41 · 2018: 35 · 2017: 42 · 2016: 35 · 2015: 29 · 2014: 32 · 2013: 25 · 2012: 23
- FWCI
- 1.76
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Journal of Pharmacy & Pharmaceutical Sciences (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, cc-by-sa)
- Funders
- Fundação para a Ciência e a Tecnologia (SFRH/BD/45145/2008)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
- Health Sciences › Medicine › Otorhinolaryngology › Sinusitis and nasal conditions
- Keywords
- intranasal drug delivery, nasal mucosa, transmucosal drug absorption, brain drug delivery, topical drug delivery, systemic drug delivery
- MeSH terms
- Absorption, Administration, Intranasal, Animals, Biological Availability, Humans, Nasal Cavity, Nasal Mucosa, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.